Opening book details…
Can I read Nanotherapeutics for the Treatment of Hepatocellular Carcinoma on EtoBox?
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma by Biswajit, Mukherjee is a book available to read on EtoBox.
What is Nanotherapeutics for the Treatment of Hepatocellular Carcinoma about?
<p>Hepatocellular carcinoma (HCC) is a leading cause of death globally. Conventional chemotherapeutic agents are unable to penetrate cancerous hepatocytes completely and are toxic to non cancerous cells and tissues. This toxicity significantly compromises the therapeutic outcome of conventional chemotherapeutic agents which is also reflected in the high mortality of the disease. Nanotherapeutics have shed new light onto HCC treatment by enabling site-specific in vivo delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes. Thus, nanotherapeutics have shown considerable potential and there is tremendous impetus for rapid translation from the pre-clinical to the clinical domain to significantly prolong the survival in HCC. In Nanotherapeutics for the Treatment of Hepatocellular Carcinoma, authoritative experts of the field have explored the important aspects of nanotherapeutics against HCC. The book exhaustively, vividly and explicitly describes the molecular pathogenesis, diagnostic aspects and nanotherapy of HCC, while also highlighting the challenges of conventional therapy and the benefits of nanotherapeutics. Chapters of the book
- Author
- Biswajit, Mukherjee
- Publisher
- Bentham Science Publishers Singapore Pte Ltd
- Published
- 2022
- Language
- EN
- ISBN
- 9789815039740
- Subjects
- Medical, Technology, Medicine
More by Biswajit, Mukherjee
Browse all works by Biswajit, Mukherjee
Similar books
- Hepatocellular Carcinoma : Diagnosis and Treatment — Brian I. Carr (2016)
- Hepatocellular Carcinoma — Joseph W. Y. Lau (2008)
- Progress in Hepatocellular Carcinoma Treatment — Kiwamu Okita; Yamaguchi Symposium on Liver Diseases (2012)
- Signaling Pathways in Hepatocellular Carcinoma — Teresa Garcia-Lezana; Juan Luis Lopez-Canovas; Augusto Villanueva (2021)
- Evidence-based Anticancer Materia Medica for Hepatocellular Carcinoma — Lei Wan (2011)
- USP22 Promotes the Proliferation and Sorafenib Resistance of Hepatocellular Carcinoma Cells via Its Deubiquitinase Activity — Xiaochen Wang1 Yijie Su1 Bei Lan1 Xuanyuan Li1 Bodi Zhang1 (2025)